Peter Garcia
Overview
Peter Garcia received an average of $3M in total compensation, including $468K in salary, at ALX ONCOLOGY HOLDINGS from 2021 to 2023. Peter Garcia also received an average of $2M at PDL BioPharma from 2013 to 2019.
- 2023
- 2022
- 2021
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
ALX ONCOLOGY HOLDINGSChief Financial Officer
ALX ONCOLOGY HOLDINGSChief Financial Officer
ALX ONCOLOGY HOLDINGSChief Financial Officer
PDL BioPharmaFormer Vice President and Chief Financial Officer
PDL BioPharmaVice President and Chief Financial Officer
PDL BioPharmaVice President and Chief Financial Officer
PDL BioPharmaVice President and Chief Financial Officer
PDL BioPharmaVice President and Chief Financial Officer
PDL BioPharmaVice President and Chief Financial Officer
PDL BioPharmaVice President and Chief Financial Officer
Source: SEC filings on April 22, 2024, April 24, 2023, July 7, 2020, April 30, 2019, April 26, 2018, April 28, 2017, and April 20, 2016.
Related executives
We found 20 more executives who work or worked at ALX ONCOLOGY HOLDINGS and PDL BioPharma.
Jason Lettmann
ALX ONCOLOGY HOLDINGS
Chief Executive Officer
Jaume Pons
ALX ONCOLOGY HOLDINGS
Chief Executive Officer
Sophia Randolph
ALX ONCOLOGY HOLDINGS
Chief Medical Officer
Dominique Monnet
PDL BioPharma
Chief Executive Officer
Christopher Stone
PDL BioPharma
General Counsel
Jill Jene
PDL BioPharma
Vice President, Business Development
Edward Imbrogno
PDL BioPharma
Chief Financial Officer
John McLaughlin
PDL BioPharma
Chief Executive Officer
News
ALX ONCOLOGY HOLDINGS CEO Jason Lettmann receives $4.9M in 2023
April 22, 2024
ALX ONCOLOGY HOLDINGS CEO Jaume Pons' 2022 pay falls 63% to $3.7M
April 24, 2023
PDL BioPharma CEO Dominique Monnet's 2019 pay jumps 168% to $6.7M
July 7, 2020
PDL BioPharma CEO John McLaughlin's 2018 pay rises 20% to $4.1M
April 30, 2019